SCHEMBL20317326

SCHEMBL20317326

Cc1ccc2cc3oc4cccc(F)c4c(=O)c3cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ DYRK1A Q13627 1/20 0.38
▸ AR P10275 3/20 0.37
▸ MAOA P21397 3/20 0.36
▸ MAOB P27338 2/20 0.36
▸ AHR P35869 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ CYP2A6 P11509 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20317289 0.86 AR (0.43) ARMAOAMAOBAHRESR1
SCHEMBL20317296 0.86 AR (0.43) ARMAOAMAOBAHRESR1
SCHEMBL20317224 0.86 AR (0.45) ALDH1A1ARMAOAMAOBAHR
SCHEMBL20330051 0.84 MAOA (0.50) ALDH1A1MAOAESR1KDM5AESR2
SCHEMBL20317302 0.83 AR (0.39) ALDH1A1DYRK1AARMAOAMAOB
SCHEMBL20317306 0.83 AR (0.39) ALDH1A1DYRK1AARMAOAMAOB
SCHEMBL20317330 0.83 MAOA (0.40) ALDH1A1DYRK1AMAOAMAOBAHR
SCHEMBL20317283 0.82 MAOA (0.58) ALDH1A1MAOAESR1KDM5AESR2
SCHEMBL20317271 0.82 MAOA (0.58) ALDH1A1MAOAESR1KDM5AESR2
SCHEMBL20346716 0.81 AHR (0.43) ALDH1A1ARMAOAMAOBAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179174-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179174-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, NR1H2, NR1H3 ALDH1A1 1200/4885DYRK1A 3869/4885AR 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback